These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 8707401)

  • 21. Aberrant expression of p53 gene product in malignant melanoma.
    Rhim KJ; Hong SI; Hong WS; Lee SY; Lee DS; Jang JJ
    J Korean Med Sci; 1994 Oct; 9(5):376-81. PubMed ID: 7702785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. P16 UV mutations in human skin epithelial tumors.
    Soufir N; Molès JP; Vilmer C; Moch C; Verola O; Rivet J; Tesniere A; Dubertret L; Basset-Seguin N
    Oncogene; 1999 Sep; 18(39):5477-81. PubMed ID: 10498902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p53 protein expression and TP53 mutations in malignant melanomas of sun-sheltered mucosal membranes versus chronically sun-exposed skin.
    Ragnarsson-Olding B; Platz A; Olding L; Ringborg U
    Melanoma Res; 2004 Oct; 14(5):395-401. PubMed ID: 15457096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic ultraviolet exposure-induced p53 gene alterations in Sencar mouse skin carcinogenesis model.
    Tong Y; Smith MA; Tucker SB
    J Toxicol Environ Health; 1997 Jun; 51(3):219-34. PubMed ID: 9183379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. UV-B-type mutations and chromosomal imbalances indicate common pathways for the development of Merkel and skin squamous cell carcinomas.
    Popp S; Waltering S; Herbst C; Moll I; Boukamp P
    Int J Cancer; 2002 May; 99(3):352-60. PubMed ID: 11992403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors.
    Tam AS; Foley JF; Devereux TR; Maronpot RR; Massey TE
    Cancer Res; 1999 Aug; 59(15):3634-40. PubMed ID: 10446974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishment of a human melanoma cell line lacking p53 expression and spontaneously metastasizing in nude mice.
    Rauth S; Kichina J; Green A; Bratescu L; Das Gupta TK
    Anticancer Res; 1994; 14(6B):2457-63. PubMed ID: 7872667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic alterations of p16INK4a and p53 genes in sporadic dysplastic nevus.
    Lee JY; Dong SM; Shin MS; Kim SY; Lee SH; Kang SJ; Lee JD; Kim CS; Kim SH; Yoo NJ
    Biochem Biophys Res Commun; 1997 Aug; 237(3):667-72. PubMed ID: 9299424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of p53 is a late event in the development of malignant melanoma.
    Lassam NJ; From L; Kahn HJ
    Cancer Res; 1993 May; 53(10 Suppl):2235-8. PubMed ID: 8485708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunophenotypic analysis of the p53 gene in non-melanoma skin cancer and correlation with apoptosis and cell proliferation.
    Stratigos AJ; Kapranos N; Petrakou E; Anastasiadou A; Pagouni A; Christofidou E; Petridis A; Papadopoulos O; Kokka E; Antoniou C; Georgala S; Katsambas AD
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):180-6. PubMed ID: 15752287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequent mutations of the p53 gene in cutaneous melanoma of the nodular type.
    Akslen LA; Monstad SE; Larsen B; Straume O; Ogreid D
    Int J Cancer; 1998 Feb; 79(1):91-5. PubMed ID: 9495365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TP53 tumor suppressor gene and skin carcinogenesis.
    Basset-Séguin N; Molès JP; Mils V; Dereure O; Guilhou JJ
    J Invest Dermatol; 1994 Nov; 103(5 Suppl):102S-106S. PubMed ID: 7963669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p53 protein detected by immunohistochemical staining is not always mutant.
    MacGeoch C; Barnes DM; Newton JA; Mohammed S; Hodgson SV; Ng M; Bishop DT; Spurr NK
    Dis Markers; 1993 Dec; 11(5-6):239-50. PubMed ID: 8082313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultraviolet-light induced p53 mutational spectrum in yeast is indistinguishable from p53 mutations in human skin cancer.
    Inga A; Scott G; Monti P; Aprile A; Abbondandolo A; Burns PA; Fronza G
    Carcinogenesis; 1998 May; 19(5):741-6. PubMed ID: 9635858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions.
    Pollock PM; Pearson JV; Hayward NK
    Genes Chromosomes Cancer; 1996 Feb; 15(2):77-88. PubMed ID: 8834170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunohistochemical detection of the gene p53 and p21 expression in cells of the malignant melanoma of the uvea].
    Tokosová E; Hermanová M; Uhmannová R; Smardová J; Hlinomazová Z
    Cesk Slov Oftalmol; 2008 Jul; 64(4):153-6. PubMed ID: 18780655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of p53 in human cutaneous melanoma cell lines.
    Montano X; Shamsher M; Whitehead P; Dawson K; Newton J
    Oncogene; 1994 May; 9(5):1455-9. PubMed ID: 8152807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The tumor suppressor gene p53 and its significance for dermatology].
    Lübbe J; Kleihues P; Burg G
    Hautarzt; 1994 Nov; 45(11):741-5. PubMed ID: 7822196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
    Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. P53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis.
    Chang KW; Sarraj S; Lin SC; Tsai PI; Solt D
    Carcinogenesis; 2000 Jul; 21(7):1441-51. PubMed ID: 10874024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.